S

Soleno Therapeutics
D

SLNO

86.480
USD
-1.55
(-1.76%)
مغلق
حجم التداول
37,511
الربح لكل سهم
-3
العائد الربحي
-
P/E
-18
حجم السوق
4,561,549,491
أصول ذات صلة
ABBV
ABBV
-0.465
(-0.24%)
190.325 USD
ALNY
ALNY
1.29
(0.39%)
329.01 USD
C
CRMD
-0.010
(-0.09%)
11.510 USD
G
GLPG
1.790
(5.80%)
32.650 USD
GSK
GSK
-0.250
(-0.65%)
37.965 USD
MRK
MRK
0.570
(0.68%)
84.730 USD
PFE
PFE
-0.555
(-2.19%)
24.810 USD
T
TTNP
-0.81000
(-15.52%)
4.41000 USD
المزيد
الأخبار المقالات

العنوان: Soleno Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulationof a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.